MANKATO, MN—Nov. 5, 2007—For more than 60 years, Carlson Craft® Business Solutions, Regency® and Label Works®, all independent entities of Mankato, Minnesota-based Taylor Corporation, have ...
NEW YORK CITY -- The newer Navitor looked increasingly viable as a transcatheter aortic valve replacement (TAVR) system, based on its largest report of commercial use to date. In the U.S., the Navitor ...
Cambridge biotech Navitor Pharmaceuticals just closed out an impressive $33 million Series B, meant to propel the research from lauded MIT and Whitehead Institute researcher Dr. David Sabatini. This ...
Navitor Pharmaceuticals, Inc., a biopharmaceutical company developing novel medicines by targeting cellular nutrient signaling, today announced a $23.5 million Series A financing. Proceeds from the ...
Paravalvular leak (PVL) was largely eliminated with the Navitor, a new iteration of the Portico transcatheter aortic valve replacement (TAVR) device boasting a new sealing cuff. In the Portico NG ...
Abbott Laboratories is making some noise in the transcatheter aortic repair/implantation market this week by announcing CE mark of its Navitor system. The device is minimally invasive and for people ...
NEW YORK, NY—Real-world TAVI experience with the self-expanding Navitor valve (Abbott) shows a high rate of technical success with few events at 30 days, according to registry data. In almost 3,000 ...
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Navitor Pharmaceuticals, Inc., a biopharmaceutical company targeting the mTORC1 pathway to develop novel therapeutics that help patients live longer and healthier ...
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...
The FDA has approved Abbott Laboratories (NYSE: ABT) latest-generation transcatheter aortic valve implantation (TAVI) system, Navitor, to treat people with severe aortic stenosis who are at high or ...
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Today, privately held Navitor Pharmaceuticals, LLC (“Navitor”), announced that Janssen Pharmaceuticals, Inc. (“Janssen”), one of the Janssen Pharmaceutical Companies ...
(RTTNews) - Abbott Laboratories (ABT) announced Tuesday that the U.S. Food and Drug Administration (FDA) has approved the company's latest-generation transcatheter aortic valve implantation (TAVI) ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results